Treatment Switch For Neuroblastoma Stem Cell Transplants
The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study being presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April 24-27. The U.S. regimen was associated with more acute toxicity to the kidneys and liver...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news
More News: Brain | Cancer & Oncology | Children | Health | Hematology | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Neuroblastoma | Neurology | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology